NACDS urges members to submit DIR comments by January 25

January 9, 2019 by Chain Drug Review Centers for Medicare & Medicaid Services’ (CMS), direct and indirect remuneration (DIR) fee reform concepts, NACDS Leading Headlines, Pharmacy

ARLINGTON, Va. — Each NACDS member company has a powerful opportunity to submit official comments to the Centers for Medicare & Medicaid Services (CMS) in support of direct and indirect remuneration (DIR) fee reform concepts described in the agency’s proposed rule, “Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses.” The